Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort
about
sameAs
Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approachUnmet Needs in LDL-C Lowering: When Statins Won't Do!Overview of guidelines for the management of dyslipidemia: EU perspectivesSex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort studyCardiovascular Disease in Women: Clinical Perspectives.Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events ofPrediction of atherosclerotic cardiovascular disease mortality in a nationally representative cohort using a set of risk factors from pooled cohort risk equations.Lipoprotein (a), an independent cardiovascular risk markerCardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management.Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.Improving medication adherence in hypercholesterolemia: challenges and solutions.Weak prediction power of the Framingham Risk Score for coronary artery disease in nonagenarians.Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care settingAssociation of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertensionValidation of the pooled cohort risk score in an Asian population - a retrospective cohort study.Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.New Pooled Cohort Risk equations: application to a recent stroke patient populationComparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapyStatin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health StudyAn analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohortCardiovascular risk perception in women: true unawareness or risk miscalculation?Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-AnalysisThe high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.The Rotterdam Study: 2016 objectives and design update.Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts.Comparing Guidelines for Statin Treatment in Canada and the United States.The new lipid guidelines: what do primary care clinicians think?Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record DataRecent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population.Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort.The new cholesterol treatment guidelines from the American College of Cardiology/American Heart Association, 2013: what clinicians need to know.Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.The Challenges of Collecting and Using Patient Care Data From Diverse Care Systems: Lessons From COMPASS.
P2860
Q26738461-F030AD67-4AEF-49D4-BA1B-5015145A8558Q26741705-164D02B0-510F-406D-A000-F47422925E96Q28069411-B4BED40B-BBE4-46B2-BFAA-3E40CFFDC396Q28652095-1DA5C772-4619-4CA9-A72B-E96CB6821D82Q30743765-2CD6467D-A217-4D73-A235-8003A9621900Q30987054-CFEC5A53-17D1-4808-8696-6F9BF5C3E9CFQ33584697-651BECC0-5F20-4374-9D83-71CA65CBCFE4Q33801207-B6B05B88-35D0-4E5D-9153-8E39148285DEQ33848763-29B307D4-F42D-44D7-A046-A196978D12CBQ33900403-1718B0B5-3F6D-4ECA-AF13-0EDC9E5F24F4Q34364949-A3F31C11-3F38-4C9B-87AF-D88BC5817936Q34482456-3A14D350-7249-45E2-84BF-CFB7C1B283E8Q34506768-3A81FFF5-08B1-4AC1-A99B-654612694F10Q34537368-597B94CF-688C-4676-97F6-2C5EB49EC3B1Q34564055-5B663853-1FCB-4F7E-84D2-8F026C9D0066Q34582520-72DB4903-821D-4772-9AEC-11D3A60C7A7DQ34795273-B7D36382-9254-4ABE-AF18-3AB1DC5060FCQ34982921-D4E7BD00-8D03-4B49-B5DE-600320B6A4ACQ35190397-42B83870-1F55-4BC1-9C7C-2A2A8221BF13Q35232279-106FFDA7-A45C-4226-A7EC-0C3389DF85FCQ35379591-233CBF43-E6F3-499A-B42A-3CCC4AC8A8A1Q35553113-85FDA907-6571-447E-9AE0-F1C737B08785Q35595708-F1911394-FB1A-4C0E-9BF8-4CEE6B318C17Q35776957-0521A6B4-536F-457B-A533-33E3392C0ED6Q35814972-49BCEABC-0081-4257-BBA4-08D7BDE655E4Q36076136-44D1D3A6-C9C2-48E1-A1FA-D810EACE8D2CQ36084114-F7CF8458-3288-41B1-B199-D3E75C6CA492Q36085712-229BA7C0-7511-468A-A673-6D2A401A579EQ36161516-0CB12E8A-F76F-4425-853E-6BB412A952F3Q36168695-1C035EC3-DA26-49E4-8CF3-AB8EBB653A67Q36331639-8079E26C-6CFF-438F-9310-6408C7D365E3Q36355669-85859EB9-9598-448F-8ED9-869EC39BC834Q36873040-51E384E3-9068-454E-B824-CF7DF71DD75AQ37240354-BC3F7EFC-D513-45EC-99B4-8E66CA5BE70DQ37396518-593311CF-3E77-4256-AA24-63E655C31367Q37613887-53E6EBDA-C4E4-4AC9-9F97-A972AD4833DCQ37680314-466234E2-CD57-433B-959E-E56B61E7D55BQ38267131-51821261-CC78-4897-9912-766EB3FA6CABQ38538716-06584D7C-4524-44F9-A554-2F0FEE695A9AQ38598279-45C45715-E29C-49A9-A926-8FF51FA17392
P2860
Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im April 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2014
@uk
name
Comparison of Application of t ...... revention in a European Cohort
@en
Comparison of Application of t ...... revention in a European Cohort
@nl
type
label
Comparison of Application of t ...... revention in a European Cohort
@en
Comparison of Application of t ...... revention in a European Cohort
@nl
altLabel
Comparison of application of t ...... revention in a European cohort
@en
Comparison of application of t ...... revention in a European cohort
@nl
prefLabel
Comparison of Application of t ...... revention in a European Cohort
@en
Comparison of Application of t ...... revention in a European Cohort
@nl
P2093
P50
P356
P1476
Comparison of Application of t ...... revention in a European Cohort
@en
Comparison of application of t ...... revention in a European cohort
@en
P2093
Bruno H Stricker
Bruno H. Stricker
Ewout W Steyerberg
Ewout W. Steyerberg
Ian M Graham
Ian M. Graham
M Arfan Ikram
M. Arfan Ikram
Maarten J G Leening
Maarten J. G. Leening
P356
10.1001/JAMA.2014.2632
P407
P577
2014-04-09T00:00:00Z